« Back to the previous page

Buyer of innovative pharmaceutical companies in Europe

Company to buy

• Size: Small scale pharma company
• Revenue: 1-5M EUR
• Investment amount: <5M EUR
• Location of the target company: EU
• Reason for acquisition: The buyer is interested in prolonging its value chain for B2B business in international markets, like Brazil, China and the EU while producing and marketing in Europe. The target would also be useful in distribution of injectable drugs across the EU and expanding the portfolio of EU-manufactured for marketing in China
• #CFIE PHB060

Overview of this Buyer of innovative pharmaceutical companies in Europe

The Buyer has specialized in pharmaceutical distribution of Active Pharmaceutical Ingredients (API), Finished Dosage Forms (FDF) and services since 1989, with dedicated teams in Brazil, China, Germany, India and Malta. 

Profile (strategy) of this Buyer of innovative pharmaceutical companies in Europe

The Buyer has made investments and joint ventures with other innovative pharmaceutical firms in the EU, Brazil and China with the aim of improving patient access to generic and innovative medicine. 

The key focus is on novel delivery systems and the provision of EU-registered and manufactured drugs. Quality is also a priority, as evidenced by the EMA, FDA and ANVISA standards for APIs and FDFs held by its products.

Activities and products of an ideal target pharma unit

This Buyer is looking for an acquisition of a small, generics manufacturer in the EU as well as investment opportunities into second and later stage health services and medicine technology. These assets are best described as healthcare products, branded prescription medicine and innovative drug delivery technology.

An innovation DNA is highly desirable, from product to delivery mechanism or online marketing.

Highlights of the Buyer of innovative pharmaceutical companies in Europe

• The buyer is part of a family office-backed EU pharmaceutical group, with footprint a in Latin America, and China and distribution activities in Africa as well.
• Established in 1989, the Buyer was merged into a century-old generic drug group and started expansion into Brazil and China
• Products include OTC food supplements as well

Information on this Buyer of innovative pharmaceutical companies in Europe

Feel free to contact us for more information regarding this Buyer of innovative pharmaceutical company in Europe, or if you know possible interested or suitable parties. For more buyers of pharmaceutical companies, please visit the section pharmaceutical companies wanted. For pharmaceutical companies for sale visit the section pharmaceutical companies for sale. For Spanish, Swedish or Swiss companies for sale please visit the relevant company pharmaceutical companies for sale.

Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual please explain as much as possible about your personal background strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.